New Research Proposals Aim to Improve Honey Bee Health
February 17, 2016
Project Apis m. to spearhead multi-year research funded by Bayer’s Healthy Hives 2020 initiative
RESEARCH TRIANGLE PARK, N.C. (Feb. 18, 2016) – Bayer and Project Apis m. today announced they are partnering to sponsor research to improve the health of honey bee colonies in the United States within the next five years.
A multi-year, $1 million research effort, Bayer’s Healthy Hives 2020 initiative brought together a diverse group of bee experts to prioritize the most urgent research areas needed to improve the health of U.S. colonies by the end of 2020. Project Apis m., the leading non-profit organization dedicated to pollination research, will oversee the administration of the Bayer-funded research grants which are focused on the following major research objectives:
- Conducting an economic assessment of the “true” cost of commercial beekeeping operations to help beekeepers maximize efficiency and production;
- Creating a set of “Best Management Practices” for commercial beekeeping based on definitive colony health performance data;
- Evaluating the use of “smart hive” technology to monitor honey bee colony health during commercial migratory operations; and,
- Assessing honey bee genetics for traits that are relevant to colony resistance to pests and diseases, as well as pollination efficiency and honey production in the United States.
“While the overall number of honey bee colonies continues to increase, they are still being impacted by a wide range of health-related issues,” said Christi Heintz, executive director of Project Apis m., Paso Robles, California. “In issuing a request for proposals, our goal is to identify scientists and promising research initiatives that can help solve some of the most critical concerns facing beekeepers today.”
Proposals should address one or more of the key focus areas and include qualifications of the research team, proposed timelines, deliverables and budget. According to Heintz, the intent is to conduct multi-year investigations with annual reports on progress toward achieving project goals. The deadline for submissions is 5 p.m., PST, Tuesday, March 1, 2016.
The new research effort arose out of Bayer’s Healthy Hives 2020 initiative, which launched in 2015 with a two-day workshop that brought together some of the nation’s leading bee health experts and stakeholders at the Bayer North American Bee Care Center in Research Triangle, North Carolina. The 17 summit workshop attendees identified a wide range of bee health concerns which were later reviewed by the Healthy Hives 2020 Steering Committee and prioritized into the most promising areas of research that were announced today.
“Today’s announcement represents a collaborative effort of some of the country’s leading bee health stakeholders including beekeepers, academic researchers, governmental officials and industry representatives,” said Dr. Steve Sheppard, professor of entomology and departmental chair at Washington State University, Pullman, Washington, who chairs the Healthy Hives 2020 Steering Committee.
Healthy Hives 2020 is one of several activities of Bayer’s North American Bee Care Program. “We have supported and promoted bee health for nearly 30 years,” said Dr. David Fischer, director of pollinator safety, Crop Science, a division of Bayer. “Because of the critical role honey bees play in crop pollination, we have long recognized that a vibrant beekeeping industry is vital to maintaining sustainable agriculture.”
Other Bayer bee health programs include:
- Establishing the North American Bee Care Center two years ago as a focal point for education, research and collaboration, hosting more than 6,000 visitors;
- Launching Feed a Bee, a major honey bee forage initiative that engaged more than 250,000 consumers last year to distribute seed to plant more than 65 million flowers; and,
- Forming more than 70 partnerships with a wide range of organizations to plant thousands of acres of forage for honey bees.
For more information on Bayer’s bee health programs, please visit www.BeeHealth.Bayer.us.
Bayer is committed to bringing new technology and solutions for agriculture and non-agricultural uses. For questions concerning the availability and use of products, contact a local Bayer representative, or visit Crop Science, a division of Bayer, online at www.CropScience.Bayer.us.
Visit the Bayer Connect - Social Hub for social media, recent news, blog posts, videos and more from Crop Science, a division of Bayer.
###
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2014, the Group employed around 119,000 people and had sales of EUR 42.2 billion. Capital expenditures amounted to EUR 2.5 billion, R&D expenses to EUR 3.6 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.Contact:
Bayer Media Hotline, 1-862-404-5118, or
Jeffrey Donald
Crop Science, a Division of Bayer
Tel: (919) 549-5395
Email: jeffrey.donald@bayer.com
Kayla Reed
Porter Novelli
Tel: (678) 428-2107
Email: kayla.reed@porternovelli.com
Find more information at CropScience.Bayer.us.
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.